Acquisitions, donations & more — 4 GI company key notes

Here are four updates on GI companies from the past week:

Takeda, Sweden-based Karolinska Institutet and The Structural Genomics Consortium entered into a precompetitive and proprietary collaboration agreement to research and test potential intervention points for inflammatory bowel disease.

Takeda Pharmaceuticals U.S.A. donated $100,000 to local and regional nonprofits as part of its annual Takeda Cares Day.

EnteroMedics acquired ReShape Medical and its ReShape Dual Weight Loss Balloon, a minimally invasive intragastric balloon system.

TransMed7, a medical device company, appointed Michael Demeure, MD, chair of its endocrine and gastrointestinal health team.

More articles on gastroenterology: 
Allergan under scrutiny for Restasis patent transfer — 4 insights
GI leader to know: Dr. Gary Varilek of Gastroenterology Specialties
Stock market week-in-review for 5 large GI companies — Oct. 2-6

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months